Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedetta Maria Bonora

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Antioxidants & Redox Signaling|September 20, 2021
Hematopoietic and Nonhematopoietic <i>p66Shc</i> Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in DiabetesMattia Albiero, Marianna D'Anna, Benedetta Maria Bonora, et al.
Stem Cells Translational Medicine|June 3, 2020
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trialBenedetta Maria Bonora, Roberta Cappellari, Marta Mazzucato, et al.
Diabetes, Obesity & Metabolism|July 22, 2020
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysisMario Luca Morieri, Benedetta Maria Bonora, Enrico Longato, et al.
The Journal of Clinical Endocrinology and Metabolism|January 5, 2018
Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic PatientsGian Paolo Fadini, Federico Boscari, Roberta Cappellari, et al.
The Journal of Clinical Endocrinology and Metabolism|December 24, 2015
Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 DiabetesGian Paolo Fadini, Benedetta Maria Bonora, Roberta Cappellari, et al.
Diabetes Research and Clinical Practice|February 6, 2021
Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine careBenedetta Maria Bonora, Mauro Rigato, Vera Frison, et al.
Journal of Endocrinological Investigation|May 10, 2025
Long-term effects of adding an SGLT-2 inhibitor to insulin therapy in patients with type 1 diabetes. An observational study and systematic review of real-world evidenceAlberto Maran, Federico Boscari, Carlo Fagarazzi, et al.
Diabetologia|August 9, 2021
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trialBenedetta Maria Bonora, Mattia Albiero, Mario Luca Morieri, et al.
European Journal of Clinical Investigation|December 13, 2023
Circulating haematopoietic stem cells and long-term outcomes of COVID-19Benedetta Maria Bonora, Marella Marassi, Paola Fogar, et al.
Diabetes, Obesity & Metabolism|March 13, 2024
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohortsGian Paolo Fadini, Benedetta Maria Bonora, Mariangela Ghiani, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Antioxidants & Redox Signaling|September 20, 2021
Hematopoietic and Nonhematopoietic <i>p66Shc</i> Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in DiabetesMattia Albiero, Marianna D'Anna, Benedetta Maria Bonora, et al.
Stem Cells Translational Medicine|June 3, 2020
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trialBenedetta Maria Bonora, Roberta Cappellari, Marta Mazzucato, et al.
Diabetes, Obesity & Metabolism|July 22, 2020
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysisMario Luca Morieri, Benedetta Maria Bonora, Enrico Longato, et al.
The Journal of Clinical Endocrinology and Metabolism|January 5, 2018
Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic PatientsGian Paolo Fadini, Federico Boscari, Roberta Cappellari, et al.
The Journal of Clinical Endocrinology and Metabolism|December 24, 2015
Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 DiabetesGian Paolo Fadini, Benedetta Maria Bonora, Roberta Cappellari, et al.
Diabetes Research and Clinical Practice|February 6, 2021
Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine careBenedetta Maria Bonora, Mauro Rigato, Vera Frison, et al.
Journal of Endocrinological Investigation|May 10, 2025
Long-term effects of adding an SGLT-2 inhibitor to insulin therapy in patients with type 1 diabetes. An observational study and systematic review of real-world evidenceAlberto Maran, Federico Boscari, Carlo Fagarazzi, et al.
Diabetologia|August 9, 2021
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trialBenedetta Maria Bonora, Mattia Albiero, Mario Luca Morieri, et al.
European Journal of Clinical Investigation|December 13, 2023
Circulating haematopoietic stem cells and long-term outcomes of COVID-19Benedetta Maria Bonora, Marella Marassi, Paola Fogar, et al.
Diabetes, Obesity & Metabolism|March 13, 2024
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohortsGian Paolo Fadini, Benedetta Maria Bonora, Mariangela Ghiani, et al.
Pageof 5